Bg pattern

NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet:Information for the patient

Nicorette BucoMist 1mg/puff oral spray solution

Nicotine

Read the entire leaflet carefullybefore starting to use thismedication,as it contains important informationfor you.

Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.
  • You should consult a doctor if your condition worsens or does not improve after 6 months of treatment with Nicorette BucoMist.

Contents of the leaflet

  1. What is Nicorette BucoMist and what is it used for
  2. What you need to know before starting to use Nicorette BucoMist
  3. How to use Nicorette BucoMist
  4. Possible side effects
  5. Storage of Nicorette BucoMist
  6. Package contents and additional information

1. What is Nicorette BucoMist and what is it used for

Nicorette BucoMist belongs to the group of medications used as an aid to quit smoking when there is an intention to quit or reduce tobacco consumption before definitively abandoning it. This type of treatment is called Nicotine Replacement Therapy (NRT).

Nicorette BucoMist alleviates the withdrawal symptoms that appear when quitting smoking, including the urge to smoke. When nicotine from tobacco is suddenly stopped from being administered to the body, various unpleasant sensations may appear, which are collectively called withdrawal syndrome. The use of Nicorette BucoMist can prevent or reduce withdrawal syndrome, including the urge to smoke. Its action is due to the fact that Nicorette BucoMist continues to administer a small amount of nicotine to the body for a short period. Nicorette BucoMist does not contain tar, carbon monoxide, or other toxins present in tobacco.

To increase the chances of quitting smoking, it is essential to have advice and support.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Nicorette BucoMist

Do not use Nicorette BucoMist

  • If you are allergic to nicotine or any of the other components of this medication (listed in section 6).
  • If you are under 18 years old.
  • If you have never smoked.

Warnings and precautions

Consult your doctor before starting to use this medication if you suffer from any of the following diseases. It is possible that you can use Nicorette BucoMist, but you will need to consult your doctor first:

  • If you have recently (up to 3 months prior) suffered a heart attackor heart stroke.
  • If you suffer from chest pain(angina pectoris) or resting angina.
  • If you suffer from any heart diseasethat affects heart rhythm or frequency.
  • If you have high blood pressure(hypertension) that is not controlled with medication.
  • If you have had an allergic reactionwith inflammation of the lips, face, and throat (angioedema) or skin irritation (urticaria). The use of nicotine replacement therapy may sometimes produce this type of reaction.
  • If you suffer from severe or moderate liver disease.
  • If you suffer from severe kidney disease.
  • If you suffer from diabetes.
  • If you have hyperactivity of the thyroid gland.
  • If you have a tumor in the adrenal medulla(pheochromocytoma).
  • If you suffer from stomach or duodenal ulcers.
  • If you have esophagitis.
  • If you have a history of epilepsyor seizures

Non-smokersshould not use Nicorette BucoMist.

Children and adolescents

Do not administer this medication to children or adolescents.

Using Nicorette BucoMist with other medications

Tell your doctor or pharmacist that you are taking, have recently taken, or may need to take any other medication. This is especially important if you take medications that contain:

  • Theophyllinefor asthma
  • Tacrinefor Alzheimer's disease
  • Clozapinefor schizophrenia
  • Ropinirolefor Parkinson's disease

Using Nicorette BucoMist with food and drinks

Do not eat or drink when applying a spray.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Pregnancy

It is very important to quit smoking during pregnancybecause it could cause intrauterine growth retardation, premature birth, or stillbirth. Ideally, you should try to quit smoking without using any nicotine medication. If you cannot, you should only use Nicorette BucoMist if your primary care physician, obstetrician, or a specialist in smoking cessation recommends it.

Breastfeeding

The use of Nicorette BucoMist should be avoided during breastfeeding, as nicotine passes into breast milk in amounts that may affect the baby. If your doctor has recommended using Nicorette BucoMist during breastfeeding, the spray or sprays should be applied immediately after breastfeeding and never during the 2 hours prior to breastfeeding.

Fertility

Smoking increases the risk of infertility in women and men. The effect of nicotine on fertility is unknown.

Driving and using machines

No effects on the ability to drive or use machines have been observed.

Nicorette BucoMistcontains 11 mg of propylene glycol per spray. This medication contains approximately 7 mg of alcohol (ethanol) in each spray, which is equivalent to 97 mg/ml. The amount of alcohol in each spray of this medication is equivalent to less than 2 ml of beer or 1 ml of wine. The small amount of alcohol in this medication will not have any noticeable effect. This medicinal product also contains less than 1 mmol of sodium (23 mg) per spray, i.e., it is essentially sodium-free. Due to the presence of butylhydroxytoluene, Nicorette BucoMist may cause skin reactions (e.g., contact dermatitis) or irritation to the eyes or mucous membranes.

3. How to use Nicorette BucoMist

Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

Nicorette BucoMist should not be used in children under 18 years old.

Consult your doctor if you have not achieved a reduction in the number of sprays or cigarette consumption after 6 weeks of treatment or if you need to use Nicorette BucoMist for more than 6 months. Normally, Nicorette BucoMist should be used for 3 months, but not more than 6 months.

The way to use Nicorette BucoMist will depend on whether you quit smoking immediately or gradually reduce the number of cigarettes before quitting completely.

Quitting smoking immediately

The goal is to quit smoking immediately and use the sprays from the device to alleviate the urge to smoke.

Do not use more than 2 sprays at a time or 4 sprays per hour for 16 hours. The maximum dose is 64 sprays for 16 hours in any 24-hour period.

Phase 1:Weeks 1-6

Perform 1 or 2 sprays when the urge to smoke appears. If after one spray the urge to smoke is not controlled in a few minutes, apply a second spray. If two sprays are needed, subsequent applications will also be two consecutive sprays. For most smokers, this means 1 or 2 sprays every 30-60 minutes.

Example: If you smoke an average of 15 cigarettes per day, you should apply 1-2 sprays, at least 15 times a day.

Phase 2:Weeks 7-9

Start reducing the number of sprays per day.

By the end of the ninth week, you should be using HALF the number of sprays you used during Phase 1.

Phase 3:Weeks 10-12

Continue reducing the number of sprays per day until you use no more than 4 sprays per day during the twelfth week. When you have reduced the sprays to 2-4 sprays per day, you should stop using Nicorette BucoMist.

Quitting smoking gradually

The goal is to start replacing some cigarettes with Nicorette BucoMist. Once this goal is achieved, quit smoking cigarettes completely and switch to using the spray device only. Finally, completely stop using the medication.

.

When you feel a strong urge to smoke, apply 1-2 sprays instead of a cigarette to help control your cravings. The sprays are to replace a cigarette, do not smoke shortly after using it. Using the sprays without reducing the number of cigarettes will make you feel unwell (see section "If you use more Nicorette BucoMist than you should"). Reduce the number of cigarettes you smoke per day as much as possible and replace them with a spray. As soon as you feel ready, you should quit smoking completely, no later than 12 weeks after starting treatment. After quitting smoking, gradually reduce the number of sprays per day. When you have reduced the sprays to 2-4 per day, stop using Nicorette BucoMist.

Do not use more than 2 sprays at a time or 4 sprays per hour for 16 hours. The maximum dose is 64 sprays for 16 hours in any 24-hour period.

After completing the treatment, you may feel the urge to smoke again. Keep the package with the unused dose of the medication for situations where you suddenly feel a strong urge to smoke. You can apply one spray, or two if the first spray does not help within a few minutes.

Follow these instructions carefully and use the diagrams as a guide

Open the mouthpiece

Medication ampoule with an arrow pointing downward indicating dose extraction with a needleMedication ampoule with an arrow pointing towards its opening and the letter b indicating the step to followMedication ampoule with curved arrows indicating rotation movements and letters c and b indicating directions

How to open the dispenser

  1. Use your thumb to slide the button (a) downward until it can be pressed lightly inward (b). Do not press too hard.
  2. While pressing the button, slide upward (c) to open the top of the dispenser.

Hand holding an inhaler with a spray mouthpiece and button pressed on a light blue backgroundHow to load the dispenser

When using Nicorette BucoMist for the first time, you need to load the spray pump. Point the mouthpiece towards a safe place for you where no other adults, children, or pets are present. Press the top of the dispenser with your index finger 3 times until a fine spray appears. If you do not use Nicorette BucoMist for 2 days, the loading procedure must be repeated.

How to use the dispenser

  1. Hand applying a green rectangular medicinal patch to the skin of the arm within a blue circlePoint the mouthpiece towards the open mouth as close as possible.
  2. Press the top of the dispenser firmly to release a spray inside the mouth, avoiding the lips. Do not inhale while applying to avoid the spray entering the throat. For better results, do not swallow in the seconds following the spray.

To remove the mouthpiece

Three green circular icons show a medical device with arrows indicating rotation and downward pressure

How to close the dispenser

  1. Slide the button (d) downward until it can be pressed inward.
  2. While pressing, slide the top of the dispenser downward (f). Release the button. The dispenser will now be closed.

To use another dose, repeat the steps mentioned above.

Close the dispenser after each use to prevent the use of Nicorette BucoMist by children or accidental sprays. Be careful not to spray your eyes during the administration of Nicorette BucoMist. If the spray comes into contact with your eyes, rinse them thoroughly with water.

If you use more Nicorette BucoMist than you should

If you smoke at the same time as using Nicorette BucoMist, you may experience symptoms of nicotine overdose.

If a child uses Nicorette BucoMist or if you use too many sprays, consult your doctor immediately, go to the nearest hospital, or call the Toxicology Information Service (phone 91 562 04 20), indicating the name and amount used. The doses tolerated by adults during treatment can cause severe symptoms of poisoning in childrenand even lead to their death.

The symptoms of overdose are nausea, vomiting, excessive salivation, stomach pain, diarrhea, sweating, headache, and dizziness, hearing disturbances, and a feeling of weakness. At high doses, these symptoms can be followed by a drop in blood pressure, weak and irregular pulse, difficulty breathing, extreme fatigue, circulatory collapse, and generalized convulsions.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Nicorette BucoMist can cause side effects, although not everyone will experience them.

Nicorette BucoMist can cause the same side effects as other forms of nicotine. These effects usually depend on the dose taken.

Effects related to quitting smoking (nicotine withdrawal)

Some of the unwanted effects experienced when quitting smoking may be withdrawal syndromes due to the decrease in nicotine consumption.

These effects include:

  • Irritability, aggression, impatience, or frustration.
  • Feeling of anxiety, agitation, or difficulty concentrating.
  • Sleep disorders.
  • Increased appetite or weight gain.
  • Depression.
  • Urgency to smoke (cravings).
  • Decreased heart rate.
  • Gum bleeding or oral ulcers.
  • Dizziness or mild disorientation.
  • Cough, sore throat, nasal congestion, or nasal discharge.
  • Constipation.

If you notice any of the following rare side effects, stop using Nicorette BucoMist and consult your doctor immediately (signs of angioedema):

  • Swelling of the face, tongue, or throat.
  • Difficulty swallowing.
  • Urticaria or difficulty breathing.

Very common: may affect more than 1 in 10 people:

  • Hiccup (particularly common).
  • Headache, nausea (feeling sick).
  • Throat irritation.

Common: may affect up to 1 in 10 people:

  • Effects at the administration site such as a burning sensation, inflammation of the mouth, or changes in taste perception.
  • Dry mouth or increased saliva production.
  • Feeling of indigestion.
  • Pain or discomfort in the abdomen.
  • Vomiting, flatulence, or diarrhea.
  • Feeling of fatigue.
  • Hypersensitivity (allergy)
  • Numbness
  • Cough

Uncommon: may affect up to 1 in 100 people:

  • Effects on the nose such as nasal congestion or sneezing.
  • Wheezing (bronchospasm), or feeling the need to breathe more strongly than normal (dyspnea), throat tightness.
  • Redness of the skin (flushing) or increased sweating.
  • Effects in the mouth such as numbness, inflammation of the tongue, oral ulcers, damage to the mouth mucosa, or changes in voice, mouth and throat pain, belching, gum bleeding.
  • Palpitations (unusual feeling of heartbeat), increased heart rate, hypertension.
  • Rashes and/or itching (pruritus, urticaria) of the skin.
  • Abnormal dreams.
  • Chest discomfort and pain.
  • Feeling of weakness, feeling of malaise.
  • Nasal discharge.

Rare: may affect up to 1 in 1,000 people:

  • Difficulty swallowing, feeling of numbness in the mouth.
  • Gagging.

Frequency not known: frequency that cannot be estimated with the available data

  • Blurred vision, increased tear production (lacrimation).
  • Dry throat, stomach discomfort, lip pain.
  • Redness of the skin.
  • Allergic reactions including swelling of the face and mouth (angioedema or anaphylaxis).
  • Abnormal heart rhythm.
  • Seizures

Reporting side effects

If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet.

You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines. Website: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Nicorette BucoMist

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date that appears on the dispenser and on the packaging after CAD. The expiry date is the last day of the month indicated.

Do not store above 30°C.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment, especially the aquatic environment in the case of nicotine.

6. Package Contents and Additional Information

Composition of Nicorette BucoMist

  • The active ingredient is nicotine. One spray releases 1 mg of nicotine.
  • The other components (excipients) are propylene glycol (E1520), anhydrous ethanol, tromethamine, poloxamer 407, glycerol (E422), sodium bicarbonate, levomenthol, peppermint flavor, refreshing aroma, sucralose, potassium acesulfame, butylhydroxytoluene (E321), hydrochloric acid, and purified water.

Appearance of the Product and Package Contents

Nicorette BucoMist consists of a plastic bottle located in a dispenser with a mechanical spray pump. The dispenser has a child safety lock.

Each bottle contains 13.2 ml of solution, equivalent to 150 sprays.

Nicorette BucoMist is supplied in packs of 1, 2, or 3 dispensers.

Nicorette BucoMist is also available in packs of 1, 2, or 3 dispensers that include, under the rear label, a near-field communication (NFC) chip that allows connectivity with the mobile application. These dispensers carry this icon>

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing authorization holder:

JNTL CONSUMER HEALTH (SPAIN), S.L.

Paseo de las Doce Estrellas 5-7

28042 Madrid

Spain

Manufacturer:

McNeil AB, P.O.

Box 941, Norrbroplatsen 2, SE-251 09 Helsingborg, Sweden

or

Johnson & Johnson Consumer NV/SA,

Michel De Braeystraat 52, 2000 Antwerp

This medicine is authorized in the Member States of the European Economic Area under the following names:

Sweden

Nicorette Pepparmint

Belgium, Netherlands

Nicorette Mint Mouth spray

Luxembourg

Nicorette Mint Spray Buccal

Denmark

Iceland, Ireland

Nicorette QuickMist

Austria,

Germany

Nicorette Mint Spray

Czech Republic, Poland, Slovak Republic

Nicorette Spray

Bulgaria, Finland, Romania

Nicorette Freshmint

Cyprus, Greece, Hungary

Nicorette Quickspray

Estonia, Latvia, Lithuania

Nicorette Coolmint

Norway, Slovenia, Croatia

Nicorette

France

Nicorettespray

Italy

Nicorettequick

Spain, Portugal

Nicorette Bucomist

Date of the last revision of this leaflet: June 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION

Discuss questions about NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89
5.0 (137)
Doctor

Taisiia Proida

Psychiatry 7 years exp.

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Camera Book a video appointment
€120

Frequently Asked Questions

Is a prescription required for NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION?
NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION?
The active ingredient in NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION is nicotine. This information helps identify medicines with the same composition but different brand names.
Who manufactures NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION?
NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION is manufactured by Jntl Consumer Health (Spain) S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to NICORETTE BUCOMIST 1 mg/puff ORAL SPRAY SOLUTION?
Other medicines with the same active substance (nicotine) include NICORAMA FRUITMINT 2 mg MEDICATED CHEWING GUMS, NICORAMA FRUITMINT 4 mg MEDICATED CHEWING GUMS, NICORAMA MINT 2 mg MEDICATED CHEWING GUMS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media